4.4 Article

Phylogeography and evolutionary history of rodent-borne hantaviruses

Journal

INFECTION GENETICS AND EVOLUTION
Volume 21, Issue -, Pages 198-204

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.meegid.2013.11.015

Keywords

Hantavirus; Rodent-borne; Evolution; Phylogeography

Ask authors/readers for more resources

Hantavirus (Family Bunyaviridae) are mostly associated to rodents and transmitted to man by inhalation of aerosolized infected excreta of these animals. The human infection by hantaviruses can lead to severe diseases such as hemorrhagic fever with renal syndrome (HFRS) in Asia and Europe, and pulmonary syndrome (HPS) in the Americas. To determine the origin, spreading and evolutionary dynamics of rodent-borne hantaviruses, 190 sequences of nucleoprotein (N) of hantaviruses identified in 30 countries, from 1985 to 2010, were retrieved from the GenBank and analyzed using the BEAST program. Our evolutionary analysis indicates that current genetic diversity of N gene of rodent-borne hantaviruses probably was originated around 2000 years ago. Hantavirus harbored by Murinae and Arvicolinae subfamilies, probably, were originated in Asia 500-700 years ago and later spread toward Siberia, Europe, Africa and North America. Hantavirus carried by Neotominae subfamily, probably, emerged 500-600 years ago in Central America and spread toward North America. Finally, hantaviruses associated to Sigmodontinae occurred in Brazil 400 years ago and were, probably, originated from Neotominae-associated virus from northern South America. These data offer subsidies to understand the time-scale and worldwide dissemination dynamics of rodent-borne hantaviruses. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Virology

Stability of SARS-CoV-2 and other airborne viruses under different stress conditions

Marcilio Jorge Fumagalli, Carlos Fabiano Capato, Luiza Antunes de Castro-Jorge, William Marciel de Souza, Eurico Arruda, Luiz Tadeu Moraes Figueiredo

Summary: This study found differences in the stability of different viruses under various conditions, such as reduced thermal stability of coxsackievirus B5 at 45 degrees Celsius and residual infectivity of SARS-CoV-2 at 55 degrees Celsius; UV light exposure was an efficient means of viral inactivation, but less effective for non-enveloped viruses; rhinovirus A16 and respiratory syncytial virus showed extreme sensitivity to acid conditions.

ARCHIVES OF VIROLOGY (2022)

Article Virology

CoronaVac and ChAdOx1 Vaccination and Gamma Infection Elicited Neutralizing Antibodies against the SARS-CoV-2 Delta Variant

Marcilio Jorge Fumagalli, Luiza Antunes Castro-Jorge, William Marciel de Souza, Patrick Orestes de Azevedo, Alana Witt Hansen, Ricardo Tostes Gazzinelli, Benedito Antonio Lopes da Fonseca, Fernando Rosado Spilki, Luiz Tadeu Moraes Figueiredo

Summary: The emergence of the Delta variant of SARS-CoV-2 has raised concerns about vaccine effectiveness. However, this study found that the Delta variant is still neutralized effectively by antibodies produced from CoronaVac or ChAdOx1 vaccination, indicating the importance of vaccination even for individuals previously infected by the Gamma variant.

VIRUSES-BASEL (2022)

Article Biochemistry & Molecular Biology

Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals

Andrea Brizzi, Charles Whittaker, Luciana M. S. Servo, Iwona Hawryluk, Carlos A. Prete Jr, William M. de Souza, Renato S. Aguiar, Leonardo J. T. Araujo, Leonardo S. Bastos, Alexandra Blenkinsop, Lewis F. Buss, Darlan Candido, Marcia C. Castro, Silvia F. Costa, Julio Croda, Andreza Aruska de Souza Santos, Christopher Dye, Seth Flaxman, Paula L. C. Fonseca, Victor E. V. Geddes, Bernardo Gutierrez, Philippe Lemey, Anna S. Levin, Thomas Mellan, Diego M. Bonfim, Xenia Miscouridou, Swapnil Mishra, Melodie Monod, Filipe R. R. Moreira, Bruce Nelson, Rafael H. M. Pereira, Otavio Ranzani, Ricardo P. Schnekenberg, Elizaveta Semenova, Raphael Sonnabend, Renan P. Souza, Xiaoyue Xi, Ester C. Sabino, Nuno R. Faria, Samir Bhatt, Oliver Ratmann

Summary: Analysis of individual-level patient records from Brazil reveals that COVID-19 mortality rates are significantly influenced by pre-pandemic geographic inequities and healthcare capacity during the pandemic. The study also documents the temporary shocks in hospital fatality rates following the spread of the Gamma variant in 14 state capitals, where more than half of hospitalized patients aged 70 years and older died. The fluctuations in Brazil's COVID-19 in-hospital fatality rates were primarily associated with geographic inequities and shortages in healthcare capacity. Approximately half of the COVID-19 deaths in hospitals in the 14 cities could have been avoided without pre-pandemic geographic inequities and healthcare pressure. Investments in healthcare resources, healthcare optimization, and pandemic preparedness are critical to minimize the impact of highly transmissible and deadly pathogens like SARS-CoV-2, especially in low- and middle-income countries.

NATURE MEDICINE (2022)

Article Chemistry, Multidisciplinary

Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction

Scott E. Guimond, Courtney J. Mycroft-West, Neha S. Gandhi, Julia A. Tree, Thuy T. Le, C. Mirella Spalluto, Maria Humbert, Karen R. Buttigieg, Naomi Coombes, Michael J. Elmore, Matthew Wand, Kristina Nystrom, Joanna Said, Yin Xiang Setoh, Alberto A. Amarilla, Naphak Modhiran, Julian D. J. Sng, Mohit Chhabra, Paul R. Young, Daniel J. Rawle, Marcelo A. Lima, Edwin A. Yates, Richard Karlsson, Rebecca L. Miller, Yen-Hsi Chen, Ieva Bagdonaite, Zhang Yang, James Stewart, Dung Nguyen, Stephen Laidlaw, Edward Hammond, Keith Dredge, Tom M. A. Wilkinson, Daniel Watterson, Alexander A. Khromykh, Andreas Suhrbier, Miles W. Carroll, Edward Trybala, Tomas Bergstrom, Vito Ferro, Mark A. Skidmore, Jeremy E. Turnbull

Summary: This study found that the synthetic HS mimetic pixatimod can interact with the receptor binding domain of the SARS-CoV-2 spike protein and directly inhibit its binding to ACE2. The results show that pixatimod can effectively inhibit the infection of multiple clinical isolates of SARS-CoV-2 virus and has broad potency against various variants. In a mouse model, pixatimod also reduces viral titers and weight loss. This study provides strong evidence for the potential use of synthetic HS mimetics as a therapeutic approach for COVID-19.

ACS CENTRAL SCIENCE (2022)

Article Pharmacology & Pharmacy

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems

Ahmed O. Shalash, Armira Azuar, Harrison Y. R. Madge, Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, Alexander A. Khromykh, Waleed M. Hussein, Keith J. Chappell, Daniel Watterson, Paul R. Young, Mariusz Skwarczynski, Istvan Toth

Summary: The SARS-CoV-2 virus has caused a global crisis with billions of infections and millions of deaths. Current DNA and mRNA vaccines have shown decreased efficacy over time, especially the Pfizer BNT162 vaccine. Variant strains have further reduced vaccine effectiveness. Peptide vaccines offer an alternative solution with greater stability and flexibility to target emerging strains.

PHARMACEUTICS (2022)

Article Immunology

Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern

Christopher L. D. McMillan, Armira Azuar, Jovin J. Y. Choo, Naphak Modhiran, Alberto A. Amarilla, Ariel Isaacs, Kate E. Honeyman, Stacey T. M. Cheung, Benjamin Liang, Maria J. Wurm, Paco Pino, Joeri Kint, Germain J. P. Fernando, Michael J. Landsberg, Alexander A. Khromykh, Jody Hobson-Peters, Daniel Watterson, Paul R. Young, David A. Muller

Summary: The study investigated a novel vaccination strategy using a modified HexaPro S protein subunit vaccine, which generated potent antibody responses capable of neutralizing various SARS-CoV-2 variants in mice. The results demonstrated the potential of this alternative vaccination approach to mitigate the impact of emerging viral variants.

VACCINES (2022)

Article Immunology

Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months Duration

Camille F. de Oliveira, Walter F. F. Neto, Carla P. da Silva, Ana Claudia S. Ribeiro, Livia C. Martins, Alana W. de Sousa, Maria N. O. Freitas, Jannifer O. Chiang, Franko A. Silva, Eder B. dos Santos, Daniele B. A. Medeiros, Gleiciane S. Pinheiro, Gleiciane F. Brandao, Valeria L. Carvalho, Raimunda S. S. Azevedo, Pedro F. C. Vasconcelos, Igor B. Costa, Iran B. Costa, Mirleide C. dos Santos, Luana S. Soares, Rayssa L. S. Bedran, James L. Ferreira, Alberto A. Amarilla, Naphak Modhiran, Christopher L. D. McMillan, Morgan E. Freney, David A. Muller, Daniel Watterson, Livia M. N. Casseb, Daniele F. Henriques

Summary: The COVID-19 pandemic is a major health threat globally, and monitoring the antibody responses to the Sinovac vaccine and SARS-CoV-2 infection has shown that receiving the vaccine after infection can lead to higher and longer-lasting responses, highlighting the need for booster doses of Sinovac to prevent severe disease.

VACCINES (2022)

Article Virology

Screening of febrile patients with suspected malaria from the Brazilian Amazon for virus infection

Mario Luis Garcia de Figueiredo, Evan P. Williams, Colleen B. Jonsson, Mohd Jaseem Khan, Marcio Roberto Teixeira Nunes, Clayton Pereira Silva de Lima, Luiz Tadeu Moraes Figueiredo, Monica Regina Farias Costa, Maria Paula Gomes Mourao, Marcus Vinicius Guimaraes Lacerda, Victor Hugo Aquino

Summary: The aim of this study was to evaluate the potential for viral infections in patients with suspected malaria but without Plasmodium infection in the Brazilian Amazon. The results showed that arboviruses are not the most frequent viral infections in these patients.

ARCHIVES OF VIROLOGY (2022)

Correction Biochemistry & Molecular Biology

Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals (May, 10.1038/s41591-022-01807-1, 2022)

Andrea Brizzi, Charles Whittaker, Luciana M. S. Servo, Iwona Hawryluk, Carlos A. Prete, William M. de Souza, Renato S. Aguiar, Leonardo J. T. Araujo, Leonardo S. Bastos, Alexandra Blenkinsop, Lewis F. Buss, Darlan Candido, Marcia C. Castro, Silvia F. Costa, Julio Croda, Andreza Aruska de Souza Santos, Christopher Dye, Seth Flaxman, Paula L. C. Fonseca, Victor E. V. Geddes, Bernardo Gutierrez, Philippe Lemey, Anna S. Levin, Thomas Mellan, Diego M. Bonfim, Xenia Miscouridou, Swapnil Mishra, Melodie Monod, Filipe R. R. Moreira, Bruce Nelson, Rafael H. M. Pereira, Otavio Ranzani, Ricardo P. Schnekenberg, Elizaveta Semenova, Raphael Sonabend, Renan P. Souza, Xiaoyue Xi, Ester C. Sabino, Nuno R. Faria, Samir Bhatt, Oliver Ratmann

NATURE MEDICINE (2022)

Article Public, Environmental & Occupational Health

Understanding Sabia virus infections (Brazilian mammarenavirus)

Ana Catharina Nastri, Amaro Nunes Duarte-Neto, Luciana Vilas Boas Casadio, William Marciel de Souza, Ingra M. Claro, Erika R. Manuli, Gloria Selegatto, Matias C. Saloma, Gabriel Fialkovitz, Mariane Taborda, Bianca Leal de Almeida, Marcello C. Magri, Ana Rubia Guedes, Laura Vieira Perdigao Neto, Fatima Mitie Sataki, Thais Guimaraes, Maria Cassia Mendes-Correa, Tania R. Tozetto-Mendoza, Marcilio Jorge Fumagalli, Yeh-Li Ho, Camila ALves Maia da Silva, Thais M. Coletti, Jacqueline Goes de Jesus, Camila M. Romano, Sarah C. Hill, Oliver Pybus, Joao Renato Rebello Pinho, Felipe Lourenco Ledesma, Yuri R. Casal, Cristina Kanamura, Leonardo Jose Tadeu de Araujo, Camila Santos da Silva Ferreira, Juliana Mariotti Guerra, Luiz Tadeu Moraes Figueiredo, Marisa Dolhnikoff, Nuno R. Faria, Ester C. Sabino, Venacio Avancini, Ferreira Alves, Anna S. Levin

Summary: This study reports two cases of Brazilian Sabi virus infection diagnosed using metagenomics. The patients presented with hepatitis, bleeding, and neurological alterations, leading to death. No nosocomial transmission was found in the contact tracing.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2022)

Article Biochemistry & Molecular Biology

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, Sandra Parker, Xaria X. Li, Danushka K. Wijesundara, Julio Aguado, Adriana Pliego Zamora, Christopher L. D. McMillan, Benjamin Liang, Nias Y. G. Peng, Julian D. J. Sng, Fatema Tuj Saima, Jenny N. Fung, John D. Lee, Devina Paramitha, Rhys Parry, Michael S. Avumegah, Ariel Isaacs, Martin W. Lo, Zaray Miranda-Chacon, Daniella Bradshaw, Constanza Salinas-Rebolledo, Niwanthi W. Rajapakse, Ernst J. Wolvetang, Trent P. Munro, Alejandro Rojas-Fernandez, Paul R. Young, Katryn J. Stacey, Alexander A. Khromykh, Keith J. Chappell, Daniel Watterson, Trent M. Woodruff

Summary: COVID-19 infection may lead to neurological symptoms similar to Parkinson's disease. The study found that SARS-CoV-2 and spike protein can directly activate the NLRP3 inflammasome in microglial cells, which may contribute to the development of neuroinflammation.

MOLECULAR PSYCHIATRY (2023)

Article Virology

Characterization of HIV-1 Transmission Clusters Inferred from the Brazilian Nationwide Genotyping Service Database

Paula Andrade, Ighor Arantes, Amilcar Tanuri, Gonzalo Bello, Tiago Graf

Summary: Studying the transmission networks of HIV-1 using genetic data can provide valuable insights into the dynamics of transmission. In Brazil, where HIV transmission has been stable, analyzing transmission clusters has helped understand the drivers of virus spread. This study analyzed a nationwide database of HIV-1 sequences and found that young men and individuals with more education were more likely to cluster together. Similar demographic features also contributed to clustering, particularly place of residence and age. Furthermore, assortativity weakened as the genetic distance threshold increased.

VIRUSES-BASEL (2022)

Article Multidisciplinary Sciences

Zika virus noncoding RNA cooperates with the viral protein NS5 to inhibit STAT1 phosphorylation and facilitate viral pathogenesis

Andrii Slonchak, Xiaohui Wang, Julio Aguado, Julian D. J. Sng, Harman Chaggar, Morgan E. Freney, Kexin Yan, Francisco J. Torres, Alberto A. Amarilla, Rickyle Balea, Yin Xiang Setoh, Nias Peng, Daniel Watterson, Ernst Wolvetang, Andreas Suhrbier, Alexander A. Khromykh

Summary: sfRNA plays an important role in the transmission of Zika virus, facilitating the virus to pass through the placenta and infect the fetal brain. It also induces apoptosis of neural progenitor cells in human brain organoids. In infected human placental cells, sfRNA inhibits multiple antiviral pathways and promotes apoptosis, with STAT1 identified as a key factor. Phosphorylation and nuclear translocation of STAT1 are reduced due to sfRNA binding to and stabilizing viral protein NS5.

SCIENCE ADVANCES (2022)

Letter Infectious Diseases

Latin America in the clutches of an old foe: Dengue

Marcel Alied, Patricia Takako Endo, Victor Hugo Aquino, Venkata Vasavi Vadduri, Nguyen Tien Huy

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Linear epitope mapping in the E and NS1 proteins of dengue and Zika viruses: Prospection of peptides for vaccines and diagnostics

Victor Hugo Aquino, Marcilio J. Fumagalli, Angelica Silva, Bento Vidal de Moura Negrini, Alejandra Rojas, Yvalena Guillen, Cynthia Bernal, Luiz Tadeu Moraes Figueiredo

Summary: This study identified epitopes recognized by serum samples from dengue and Zika patients on the proteins of DENV and ZIKV. Epitope hotspots were found with high recognition rates, and the serum samples from dengue and Zika patients showed cross-reactivity with peptides in the DENV and ZIKV proteins. These hotspots may have greater potential for diagnostic tests and vaccine development.

PLOS ONE (2023)

No Data Available